07/11/2025
4:02 PM | Liminatus Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2025
10:40 AM | Liminatus Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2025
5:42 PM | KH Feelux Co., Ltd (Filed by)
Liminatus Pharma (Subject)
| Form SCHEDULE 13G | |
06/27/2025
5:16 PM | KH Feelux Co., Ltd (Reporting)
Liminatus Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2025
4:19 PM | Liminatus Pharma (Subject)
Nongae Apple Association 1st (Filed by)
| Form SCHEDULE 13G | |
06/26/2025
4:19 PM | Ewon Comfortech Co., Ltd. (Filed by)
Liminatus Pharma (Subject)
| Form SCHEDULE 13G | |
06/26/2025
4:20 PM | Liminatus Pharma (Subject)
Red Peony Association 1st (Filed by)
| Form SCHEDULE 13G | |
06/24/2025
3:49 PM | Liminatus Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/24/2025
2:03 PM | Liminatus Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2025
5:03 AM | Liminatus Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
8:19 PM | Kim Chris (Reporting)
Liminatus Pharma (Issuer)
Valetudo Therapeutics LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for LIMN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. |
06/04/2025
3:31 PM | Liminatus Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
8:43 PM | Liminatus Pharma (Filer)
| Form 8-K/A | |
05/30/2025
8:45 PM | Liminatus Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
4:11 PM | Liminatus Pharma (Subject)
Valetudo Therapeutics LLC (Filed by)
| Form SCHEDULE 13D | |
05/06/2025
4:20 PM | Liminatus Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
5:00 AM | Lee Eun Sook (Reporting)
Liminatus Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2025
8:53 PM | Baek Ji Yeon (Reporting)
Liminatus Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2025
6:12 PM | Liminatus Pharma (Issuer)
Yoo Byong Chul (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2025
6:14 PM | Choi Beom Kyu (Reporting)
Liminatus Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2025
6:15 PM | Kim Chris (Reporting)
Liminatus Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2025
5:26 PM | Dam Scott (Reporting)
Liminatus Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2025
5:28 PM | Fernandez Nicholas (Reporting)
Liminatus Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2025
5:29 PM | Lee Sang-Jin (Reporting)
Liminatus Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2025
3:59 PM | Liminatus Pharma (Filer)
| Form 424B3 | |
02/06/2025
11:15 PM | Liminatus Pharma (Filer)
| Form EFFECT | |
01/16/2025
5:09 AM | Liminatus Pharma (Filer)
| Form POS AM | |
11/08/2024
4:03 PM | Liminatus Pharma (Filer)
| Form POS AM | |
08/09/2024
8:34 PM | Liminatus Pharma (Filer)
| Form 424B3 | |
08/11/2024
11:15 PM | Liminatus Pharma (Filer)
| Form EFFECT | |
08/08/2024
7:52 PM | Liminatus Pharma (Filer)
| Form S-4/A | |
08/07/2024
8:15 AM | Liminatus Pharma (Filer)
| Form S-4/A | |
07/25/2024
4:29 PM | Liminatus Pharma (Filer)
| Form S-4/A | |
